Inventor
BURNETT G LESLIE
US12 patents
Patents
12 patentsUS11739074B2Aug 29, 2023
Ras inhibitors
REVOLUTION MEDICINES INC9 citations84
US11364300B2Jun 21, 2022
C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors
REVOLUTION MEDICINES INC6 citations84
US11690915B2Jul 4, 2023
Ras inhibitors
REVOLUTION MEDICINES INC9 citations82
US10980889B1Apr 20, 2021
C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors
REVOLUTION MEDICINES INC8 citations81
US12202845B2Jan 21, 2025
Ras inhibitors
REVOLUTION MEDICINES INC3 citations74
US12252497B2Mar 18, 2025
Ras inhibitors
REVOLUTION MEDICINES INC3 citations73
US12048749B2Jul 30, 2024
C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors
REVOLUTION MEDICINES INC3 citations73
US12187746B2Jan 7, 2025
C26-linked rapamycin analogs as mTOR inhibitors
REVOLUTION MEDICINES INC5 citations72
US11685749B2Jun 27, 2023
C26-linked rapamycin analogs as mTOR inhibitors
REVOLUTION MEDICINES INC5 citations72
US11168102B1Nov 9, 2021
Bicyclic heteroaryl compounds and uses thereof
REVOLUTION MEDICINES INC5 citations70
US12544448B2Feb 10, 2026
C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors
REVOLUTION MEDICINES INC0 citations61
US12258366B2Mar 25, 2025
Bicyclic heteroaryl compounds and uses thereof
REVOLUTION MEDICINES INC0 citations59